Lexaria Bioscience Corp

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$5.40

+0.06 (+1.12%)

As of Aug 8, 2:28 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +389.4% upside

Low Target $20.55

Average Target $26.43

High Target $40.48

Current Price $5.40

Current
$5.40

Target
$26.43

$20.55 $26.43 avg $40.48

Scenario Analysis

Bear Case

$20.55

280.6%

Low target

Base Case

$26.43

+389.4%

Avg target

Bull Case

$40.48

+649.6%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$23.25

-76.8% from high

52-Week Low

$4.21

+28.3% from low

Target vs 52W High

$26.43

+13.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%